Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 24 studies with search of: | "9-nitrocamptothecin" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
|
||||
2 | Completed |
Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
|
||||
3 | Recruiting |
Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
|
||||
4 | Recruiting |
Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
|
||||
5 | Completed |
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
|
||||
6 | Completed |
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
|
||||
7 | Active, not recruiting |
Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
|
||||
8 | Completed |
Pharmacology Study of Aerosolized Liposomal
|
||||
9 | Completed |
Nitrocamptothecin in Treating Patients With Metastatic Melanoma
|
||||
10 | Completed |
Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
|
||||
11 | Completed |
Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas
|
||||
12 | Active, not recruiting |
Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
|
||||
13 | Active, not recruiting |
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
|
||||
14 | Active, not recruiting |
Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
|
||||
15 | Active, not recruiting |
Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
|
||||
16 | Active, not recruiting |
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
|
||||
17 | Active, not recruiting |
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
|
||||
18 | Active, not recruiting |
Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer
|
||||
19 | Active, not recruiting |
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
|
||||
20 | Completed |
Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
|
Previous Page | Studies Shown (1-20) | Next Page (21-24) |